Development of Antiprotozoal Drugs
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Parasitology".
Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 2037
Special Issue Editors
Interests: Leishmania; Trypanosoma; Acanthamoeba; chemotherapy; treatment
Special Issues, Collections and Topics in MDPI journals
Interests: free-living amoebae; chemotherapy, natural origin products; kinetoplastids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Protozoan parasites that are infectious to humans represent a significant threat to health and cause more than one million deaths annually. They also threaten the lives of billions of individuals worldwide and are associated with significant morbidity and large economic impacts. The significant burden of human protozoan infections has been exacerbated by the lack of effective vaccines for any of the diseases caused by these parasites. Treatment and prophylaxis have, therefore, been dependent on drugs, many of which have become less effective, necessitating the search for replacements.
The limited existing therapeutic options to control protozoan infections in humans call for greater commitment from the scientific community to research how to improve the prognosis of diseases such as malaria, leishmaniasis, trypanosomiasis, giardiasis, etc., as well as the development of innovative approaches for disease control.
This Special Issue of Microorganisms will collect relevant articles that report on recent advances in antiparasitic research, from basic to translational studies. We invite your contributions, either in the form of original research or review articles, covering various aspects of research into new therapies, including molecular and cell biology, physiology and the development of new drug combinations or formulations.
Dr. Atteneri López Arencibia
Dr. Ines Sifaoui
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug discovery
- chemotherapy
- parasite
- protozoa
- formulations
- combined therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
